7 research outputs found

    Palladium-Catalyzed C–H Functionalization Using Guanidine as a Directing Group: Ortho Arylation and Olefination of Arylguanidines

    No full text
    Palladium-catalyzed C–H functionalization using guanidine as the directing group was achieved under mild reaction conditions. Various guanidine derivatives were produced in moderate to good yields by using simple unactivated arenes or ethyl acrylate as the source of arylation or olefination, respectively

    Substrate-Controlled Synthesis of Spirocyclo­propyl­pyrazolones and Bicyclic 4,5-Dihydropyrazoles from 1,2-Diaza-1,3-dienes with Sulfur Ylides

    No full text
    Substrate-controlled reactions have been developed for the synthesis of spirocyclo­propyl­pyrazolones and bicyclic 4,5-dihydropyrazoles from 1,2-diaza-1,3-dienes and sulfur ylides. These protocols were carried out under mild reaction conditions without any additives in generally moderate to good yields. Plausible mechanisms for the transformations were proposed

    Tuning the Annulation Reactivity of Vinyl Azides and Carbazates: A Divergent Synthesis of Aza-pyrimidinones and Imidazoles

    No full text
    A divergent cascade annulation has been developed using readily available vinyl azides and carbazates with a wide range of substituents. Vinyl azides were successfully applied as bifunctional partners to prepare aza-pyrimidinones via 6-ring closure with carbazates as well as to construct polyfunctionalized imidazoles via 5-ring closure with <i>N</i>-substituted carbazates. The aza-heterocycles were obtained with high levels of chemoselectivity and excellent yields

    One-Pot Three-Component Approach to the Synthesis of Polyfunctional Pyrazoles

    No full text
    A simple, multicomponent, and straightforward reaction of vinyl azide, aldehyde, and tosylhydrazine affords the construction of 3,4,5-trisubstituted 1<i>H</i>-pyrazoles regioselectively in the presence of base with moderate to excellent yields. A range of functionality could be tolerated in this methodology, and a possible mechanism is proposed

    Direct Access to 3‑Thioether-Substituted Dihydrofuro[2,3‑<i>b</i>]benzofurans via Tandem Reactions of Sulfur Ylides and 2‑Nitrobenzofurans

    No full text
    The synthesis of 3-thioether-substituted dihydrofuro[2,3-b]benzofurans involving the [3 + 2] coupling of sulfur ylides with 2-nitrobenzofurans has been realized in moderate to good yields under mild conditions without any precious catalysts or additives. It is worth mentioning that the reutilization of the departed nitro-anion in the reaction process facilitates this new chemical transformation and presents a manner of high atom economy to provide products with a complex structure

    Synthesis of Pyrimidopyrrolopyridazines via a Tandem Reaction of Heterocyclic Ketene Aminals with 1,2-Diaza-1,3-dienes

    No full text
    A tandem reaction of heterocyclic ketene aminals and 1,2-diaza-1,3-dienes was developed for the expedient synthesis of pyrimidopyrrolopyridazine derivatives. This process involved an intramolecular conjugate addition followed by CuCl<sub>2</sub>-catalyzed hydrazone formation

    A Chemical Tuned Strategy to Develop Novel Irreversible EGFR-TK Inhibitors with Improved Safety and Pharmacokinetic Profiles

    No full text
    Gatekeeper T790 M mutation in EGFR is the most prevalent factor underlying acquired resistance. Acrylamide-bearing quinazoline derivatives are powerful irreversible inhibitors for overcoming resistance. Nevertheless, concerns about the risk of nonspecific covalent modification have motivated the development of novel cysteine-targeting inhibitors. In this paper, we demonstrate that fluoro-substituted olefins can be tuned to alter Michael addition reactivity. Incorporation of these olefins into the quinazoline templates produced potent EGFR inhibitors with improved safety and pharmacokinetic properties. A lead compound <b>5a</b> was validated against EGFR<sup>WT</sup>, EGFR<sup>T790M</sup> as well as A431 and H1975 cancer cell lines. Additionally, compound <b>5a</b> displayed a weaker inhibition against the EGFR-independent cancer cell line SW620 when compared with afatinib. Oral administration of <b>5a</b> at a dose of 30 mg/kg induced tumor regression in a murine-EGFR<sup>L858R/T790M</sup> driven H1975 xenograft model. Also, <b>5a</b> exhibited improved oral bioavailability and safety as well as favorable tissue distribution properties and enhanced brain uptake. These findings provide the basis of a promising strategy toward the treatment of NSCLC patients with drug resistance
    corecore